Shilpa Medicare recalls
FDA enforcement reports naming Shilpa Medicare Limited as the recalling firm.
- Recall reports
- 8
- Class I (serious)
- 0
- Most recent report
- Aug 26, 2026
- Aug 26, 2026PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only…Drug · Shilpa Medicare LimitedDiscolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vialsClass II
- Aug 26, 2026PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only,…Drug · Shilpa Medicare LimitedDiscolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vialsClass II
- Dec 16, 2020Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx On…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II
- Dec 16, 2020Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Med…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II
- Dec 16, 2020Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be dilute…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II
- Dec 16, 2020Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only,…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II
- Dec 16, 2020Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Med…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II
- Dec 16, 2020Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx On…Drug · Shilpa Medicare LimitedCGMP DeviationsClass II